Ablynx Competitors and Similar CompaniesClear all
ImmunoGen's competitors and similar companies include CytomX Therapeutics and Innate Pharma.
 ImmunoGen ImmunoGen is a biotechnology company focused on the development of antibody-drug conjugates (ADCs) to improve outcomes for cancer patients. |  CytomX Therapeutics CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform. |  Innate Pharma Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients. | |
Founding Date | Founding Date 1981 | Founding Date 2008 | Founding Date 1999 |
Type | Type Public | Type Public | Type Public |
Tags | |||
Locations | Locations Waltham, US HQ | Locations South San Francisco, US HQ | Locations Marseille, FR HQ Rockville, US |
Employees | Employees 277161% increase | Employees 15815% increase | Employees 181 |
Valuation ($) | Valuation ($) 8.7 b | Valuation ($) 78 m | Valuation ($) 148.6 m |
Financial | |||
Revenue (est.) | Revenue (est.) $108.8m (FY, 2022) | Revenue (est.) $76.2m (FY, 2025) | Revenue (est.) €2.8m (FY, 2025) |
Cost of goods | Cost of goods $176k (FY, 2022) | Cost of goods N/A | Cost of goods €266k (FY, 2025) |
Gross profit | Gross profit $108.6m (FY, 2022) | Gross profit N/A | Gross profit €8.7m (FY, 2025) |
Net income | Net income ($222.9m) (FY, 2022) | Net income ($17.4m) (FY, 2025) | Net income (€49.2m) (FY, 2025) |
Operating ⚠ | |||
Phase I Trials Products | Phase I Trials Products N/A | Phase I Trials Products 1 (FY, 2016) | Phase I Trials Products 3 (Q2, 2019) |
Pre-Clinical Phase Products | Pre-Clinical Phase Products N/A | Pre-Clinical Phase Products 4 (FY, 2016) | Pre-Clinical Phase Products 7 (Q2, 2019) |
Funding | |||
Total funding raised | Total funding raised $ 56m | Total funding raised $ 132.4m | Total funding raised $ 94.1m |
For sources of this data, please see the company profile
View Company Profiles
CytomX Therapeutics
HQ
South San Francisco, US
Employees
158↑ 15% increase
CytomX is an oncology-focused biopharmaceutical company pioneering a novel class of antibody therapeutics based on Probody technology platform.
View companyInnate Pharma
HQ
Marseille, FR
Employees
181
Innate Pharma is a clinical-stage biotechnology company with a focus on discovering and developing therapeutic antibodies that harness the innate immune system to improve cancer treatment and clinical outcomes for patients.
View company